Gagnon Securities LLC Sells 6,035 Shares of The Pennant Group, Inc. (NASDAQ:PNTG)

Gagnon Securities LLC lessened its stake in shares of The Pennant Group, Inc. (NASDAQ:PNTG) by 3.7% during the 4th quarter, HoldingsChannel.com reports. The fund owned 156,774 shares of the company’s stock after selling 6,035 shares during the period. Gagnon Securities LLC’s holdings in The Pennant Group were worth $4,158,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of PNTG. The Manufacturers Life Insurance Company increased its position in The Pennant Group by 4.4% during the second quarter. The Manufacturers Life Insurance Company now owns 11,227 shares of the company’s stock worth $260,000 after buying an additional 471 shares during the last quarter. Creative Planning lifted its stake in shares of The Pennant Group by 2.0% in the 2nd quarter. Creative Planning now owns 19,152 shares of the company’s stock valued at $444,000 after acquiring an additional 373 shares during the last quarter. SG Americas Securities LLC acquired a new stake in The Pennant Group in the third quarter valued at $390,000. USA Financial Formulas acquired a new stake in The Pennant Group in the third quarter valued at $121,000. Finally, Kings Path Partners LLC acquired a new stake in The Pennant Group during the 3rd quarter worth about $277,000. Institutional investors own 85.88% of the company’s stock.

The Pennant Group Trading Down 3.7 %

Shares of PNTG stock opened at $26.47 on Friday. The company has a 50 day moving average of $28.21 and a 200-day moving average of $30.91. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.58. The Pennant Group, Inc. has a 12-month low of $14.84 and a 12-month high of $37.13. The firm has a market cap of $909.24 million, a P/E ratio of 38.93, a PEG ratio of 2.44 and a beta of 1.93.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on PNTG. Truist Financial reduced their target price on The Pennant Group from $38.00 to $32.00 and set a “hold” rating for the company in a research note on Monday, January 6th. Oppenheimer raised their price target on shares of The Pennant Group from $34.00 to $37.00 and gave the company an “outperform” rating in a research report on Friday, November 8th. Wells Fargo & Company initiated coverage on shares of The Pennant Group in a research report on Thursday, December 19th. They issued an “equal weight” rating and a $33.00 price target on the stock. Royal Bank of Canada raised their price target on shares of The Pennant Group from $26.00 to $38.00 and gave the company an “outperform” rating in a research report on Wednesday, October 23rd. Finally, Stephens reaffirmed an “overweight” rating and issued a $40.00 price target on shares of The Pennant Group in a research report on Wednesday, October 9th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $36.00.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.